GlassScriptPhysician profile
Caitlin E Liberatore
NPI 1508521253
$4,745.18
in general payments reported to CMS, 2019-2025
19 companies · $1,808 in 2025
The $1,808 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $154 · 2022: $852 · 2023: $1,239 · 2024: $692 · 2025: $1,808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,658 · Education: $80.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,658.12 |
| Education | $80.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $551.74 | 2021-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $539.33 | 2022-2025 | |
| Incyte Corporation | $487.33 | 2022-2025 | Opzelura |
| Pfizer INC. | $385.63 | 2022-2025 | |
| Lilly USA, LLC | $361.64 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Genzyme Corporation | $301.38 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $284.70 | 2023-2025 | Dupixent |
| Arcutis Biotherapeutics, INC. | $267.75 | 2024-2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $263.87 | 2022-2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $223.03 | 2021-2025 | Winlevi, Absorica Ld |
| Galderma Laboratories, L.P. | $219.36 | 2022-2024 | Aklief, Oracea, Epsolay |
| Janssen Biotech, INC. | $177.61 | 2023-2025 | Tremfya, Simponi, Simponi Aria |
| Organon LLC | $176.50 | 2025 | Vtama |
| Leo Pharma INC. | $146.08 | 2025 | Anzupgo, Adbry |
| Medimetriks Pharmaceuticals, INC. | $118.44 | 2024-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $110.73 | 2025 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.77 | 2024-2025 | Cabtreo, Jublia, Siliq |
| Dermavant Sciences, INC. | $46.12 | 2023-2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $30.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Liberatore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.